Clinical Trial Update: Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Metazym in late infantile Metachromatic Leukodystrophy (MLD) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metachromatic Leukodystrophy

Drugs mentioned

• METAZYM

Snippet

Sponsor: Shire | Conditions: Metachromatic Leukodystrophy (MLD) | Phase 1 | Status: COMPLETED | Results posted: 2015-08-13